Wieslab
Wieslab develops immunoassays for regulated studies and overcomes issues through a structured approach to assay development. With more than 25 years of experience in developing, optimising and running immunoassays, the company provides sensitive and robust assays that perform throughout its clients' studies. Wieslab provides a wide range of immunoassays, including enzyme-linked immunosorbent assay (ELISA), mesoscale discovery (MSD), and cell-based assays. Its service features method development, sample analysis, optimisation and validation, which are all performed in a laboratory information management system (LIMS) environment.
Last updated on
About Wieslab
Estimated Revenue
$10M-$50MEmployees
51-250Category
Industry
BiotechnologyLocation
City
MalmoeState
SkaneCountry
SwedenWieslab
Find your buyer within Wieslab